Stay updated on ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial

Sign up to get notified when there's something new on the ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website footer now identifies the site as revision v3.8.1 instead of v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-18T01:44:01.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-03T23:00:06.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” was added. The site revision changed from v3.7.1 to v3.7.2.
    Difference
    0.6%
    Check dated 2026-10-20T22:14:03.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-06T22:17:49.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A new version entry on 2026-09-14 records an update to the Study Status and upgrades the record revision to v3.7.0. The old entry for 2025-05-23 (Revision: v3.6.6) was removed from the history.
    Difference
    0.4%
    Check dated 2026-09-15T22:26:41.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The record history now includes a new Revision: v3.6.6 and removes the previous Revision: v3.6.5, updating the page's version metadata.
    Difference
    0.1%
    Check dated 2026-09-01T18:26:40.000Z thumbnail image

Stay in the know with updates to ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ONC-392 Safety, PK & Efficacy in Solid Tumors & NSCLC Clinical Trial page.